Asymptotic r(2) Enhancement in Formulation-Optimized Lipid-Iron Oxide Nanoparticles for Assessing Glioblastoma Heterogeneity at Ultrahigh-Field MRI.
- DOI
- 10.1002/smll.76488
- Published
- 2026 Oct 31
- Container
- Small (Weinheim an der Bergstrasse, Germany)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/smll.76488,
title = {Asymptotic r(2) Enhancement in Formulation-Optimized Lipid-Iron Oxide Nanoparticles for Assessing Glioblastoma Heterogeneity at Ultrahigh-Field MRI.},
author = {Bazarra-Barreiros M and Abengoza-Bello MT and Fernández-Rodicio S and Ortega-Espina S and García-Astray L and Castillo J and Iglesias-Rey R and García-Acevedo P and Hervella P},
year = {2026},
journal = {Small (Weinheim an der Bergstrasse, Germany)},
doi = {10.1002/smll.76488},
url = {https://doi.org/10.1002/smll.76488}
}RIS
TY - JOUR TI - Asymptotic r(2) Enhancement in Formulation-Optimized Lipid-Iron Oxide Nanoparticles for Assessing Glioblastoma Heterogeneity at Ultrahigh-Field MRI. AU - Bazarra-Barreiros M AU - Abengoza-Bello MT AU - Fernández-Rodicio S AU - Ortega-Espina S AU - García-Astray L AU - Castillo J AU - Iglesias-Rey R AU - García-Acevedo P AU - Hervella P PY - 2026 JO - Small (Weinheim an der Bergstrasse, Germany) DO - 10.1002/smll.76488 UR - https://doi.org/10.1002/smll.76488 ER -
APA
M, B., MT, A., S, F., S, O., L, G., J, C., R, I., P, G., & P, H. (2026). Asymptotic r(2) Enhancement in Formulation-Optimized Lipid-Iron Oxide Nanoparticles for Assessing Glioblastoma Heterogeneity at Ultrahigh-Field MRI.. Small (Weinheim an der Bergstrasse, Germany). https://doi.org/10.1002/smll.76488
Source records
- pubmed · retrieved 2026-11-10T06:53:47.242Z